DE69727398D1 - Zusammensetzungen und verfahren zur topischen anwendungen von wirkstoffen - Google Patents

Zusammensetzungen und verfahren zur topischen anwendungen von wirkstoffen

Info

Publication number
DE69727398D1
DE69727398D1 DE69727398T DE69727398T DE69727398D1 DE 69727398 D1 DE69727398 D1 DE 69727398D1 DE 69727398 T DE69727398 T DE 69727398T DE 69727398 T DE69727398 T DE 69727398T DE 69727398 D1 DE69727398 D1 DE 69727398D1
Authority
DE
Germany
Prior art keywords
compositions
pharmaceutical
methods
epidermis
drug delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69727398T
Other languages
English (en)
Other versions
DE69727398T2 (de
Inventor
W Osborne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tolmar Therapeutics Inc
Original Assignee
ViroTex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ViroTex Corp filed Critical ViroTex Corp
Publication of DE69727398D1 publication Critical patent/DE69727398D1/de
Application granted granted Critical
Publication of DE69727398T2 publication Critical patent/DE69727398T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
DE69727398T 1996-09-11 1997-09-10 Zusammensetzungen und verfahren zur topischen anwendungen von wirkstoffen Expired - Lifetime DE69727398T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/712,454 US5863560A (en) 1996-09-11 1996-09-11 Compositions and methods for topical application of therapeutic agents
US712454 1996-09-11
PCT/US1997/015919 WO1998010746A1 (en) 1996-09-11 1997-09-10 Compositions and methods for topical application of therapeutic agents

Publications (2)

Publication Number Publication Date
DE69727398D1 true DE69727398D1 (de) 2004-03-04
DE69727398T2 DE69727398T2 (de) 2004-11-25

Family

ID=24862185

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69727398T Expired - Lifetime DE69727398T2 (de) 1996-09-11 1997-09-10 Zusammensetzungen und verfahren zur topischen anwendungen von wirkstoffen

Country Status (11)

Country Link
US (3) US5863560A (de)
EP (1) EP0957900B1 (de)
JP (2) JP4276298B2 (de)
AT (1) ATE258426T1 (de)
AU (1) AU737365B2 (de)
CA (1) CA2265461C (de)
DE (1) DE69727398T2 (de)
DK (1) DK0957900T3 (de)
ES (1) ES2212128T3 (de)
PT (1) PT957900E (de)
WO (1) WO1998010746A1 (de)

Families Citing this family (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030157036A1 (en) * 2002-02-20 2003-08-21 Osborne David W. Topical dapsone for the treatment of acne
US5863560A (en) * 1996-09-11 1999-01-26 Virotex Corporation Compositions and methods for topical application of therapeutic agents
US6787157B1 (en) * 1998-03-10 2004-09-07 Abbott Laboratories Multiphase active ingredient-containing formulations
US6294188B1 (en) 1998-07-09 2001-09-25 Aviana Biopharm Inc. Methods involving changing the constitutive and stimulated secretions of the local reproductive system of women
CA2366458A1 (en) * 2000-01-31 2001-08-16 Collaborative Technologies, Inc. Method and system for producing customized cosmetic and pharmaceutical formulations on demand
US20040092494A9 (en) * 2000-08-30 2004-05-13 Dudley Robert E. Method of increasing testosterone and related steroid concentrations in women
US20040002482A1 (en) * 2000-08-30 2004-01-01 Dudley Robert E. Androgen pharmaceutical composition and method for treating depression
US6503894B1 (en) * 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US20020193321A1 (en) * 2000-12-12 2002-12-19 Mohan Vishnupad Dual dispenser for aesthitically acceptable delivery of anhydrous skin treatment compositions
US6495596B1 (en) 2001-03-23 2002-12-17 Biozibe Laboratories, Inc. Compounds and methods for inhibition of phospholipase A2 and cyclooxygenase-2
US6998421B2 (en) 2001-06-07 2006-02-14 Biozone Laboratories, Inc. Compounds and methods for inhibition of phospholipase A2 and cyclooxygenase - 2
US6475526B1 (en) 2001-06-05 2002-11-05 Jeffrey B. Smith Zinc containing compositions for anti-viral use
US20040072810A1 (en) 2001-11-07 2004-04-15 Besins International Belgique Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof
US20030144362A1 (en) * 2002-01-28 2003-07-31 Utterberg David S. High viscosity antibacterials for cannulae
US20050042240A1 (en) * 2002-01-28 2005-02-24 Utterberg David S. High viscosity antibacterials
WO2003092704A1 (fr) * 2002-04-30 2003-11-13 Mochida Pharmaceutical Co., Ltd. Preparation externe de vidarabine a propriete systemique amelioree
US20040086469A1 (en) * 2002-10-30 2004-05-06 Osborne David W. Protectant for UV-induced skin damage
US6855341B2 (en) * 2002-11-04 2005-02-15 Jeffrey B. Smith Anti-viral compositions and methods of making and using the anti-viral compositions
US20080274209A1 (en) * 2002-11-04 2008-11-06 Integritas Pharma, Inc. Methods of treating inflammation
JP4591746B2 (ja) * 2002-12-03 2010-12-01 大正製薬株式会社 難溶性抗ウイルス成分含有水溶性外用剤組成物
WO2004105662A1 (en) * 2003-05-23 2004-12-09 Program For Appropriate Technology In Health Microbicidal compositions and methods of use
US7186416B2 (en) * 2003-05-28 2007-03-06 Stiefel Laboratories, Inc. Foamable pharmaceutical compositions and methods for treating a disorder
US20060229258A1 (en) * 2003-07-30 2006-10-12 Daniela Serikaku Steroidal compositions containing hydroxycarboxylic acids and methods of using the same
JP2007533606A (ja) * 2003-08-13 2007-11-22 キューエルティー・ユーエスエイ・インコーポレーテッド ダプソンを含む乳化組成物
US20060204526A1 (en) * 2003-08-13 2006-09-14 Lathrop Robert W Emulsive composition containing Dapsone
US20050191338A1 (en) * 2004-01-30 2005-09-01 Lifeng Kang Transdermal drug delivery composition comprising a small molecule gel and process for the preparation thereof
WO2006004759A2 (en) * 2004-06-29 2006-01-12 Mcclellan Stephanie N Topical compositions for anti-aging
US20060024372A1 (en) * 2004-07-29 2006-02-02 Utterberg David S High viscosity antibacterials
US20060079558A1 (en) * 2004-09-27 2006-04-13 Bridge Pharma. Inc. R-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine and other dermal anesthetics
WO2006036936A2 (en) * 2004-09-27 2006-04-06 Bridge Pharma, Inc. The s-isomer of 2-{2-[n-(2-indanyl)-n-phenylamino]ethyl}piperidine and other dermal anesthetic agents
NZ554559A (en) 2004-10-27 2010-05-28 Univ Florida Adrenocorticotropic hormone (ACTH) analogs and related methods
US20070088012A1 (en) * 2005-04-08 2007-04-19 Woun Seo Method of treating or preventing type-2 diabetes
JP2008536937A (ja) * 2005-04-20 2008-09-11 ザイロス コーポレイション 経皮薬物送達系に用いる微生物セルロース材料、製造および使用方法
US20060271262A1 (en) * 2005-05-24 2006-11-30 Mclain Harry P Iii Wireless agricultural network
WO2008018854A2 (en) * 2005-06-06 2008-02-14 The Rockefeller University Bactiophage lysins for bacillus anthracis
US20100154146A1 (en) 2008-07-02 2010-06-24 S.C. Johnson & Son, Inc. Carpet decor and setting solution compositions
US8846154B2 (en) 2005-06-07 2014-09-30 S.C. Johnson & Son, Inc. Carpet décor and setting solution compositions
US7582291B2 (en) * 2005-06-30 2009-09-01 The Rockefeller University Bacteriophage lysins for Enterococcus faecalis, Enterococcus faecium and other bacteria
ITMI20051417A1 (it) * 2005-07-22 2007-01-23 Mipharm S P A Formulazione topica in forma di gel contenente come ingredienti attivi ciclovit e lidocaina
US20090176743A1 (en) * 2005-07-29 2009-07-09 Priscilla Schaffer Methods for treating or preventing reactivation of a latent herpesvirus infection
EP2360248A1 (de) 2005-08-24 2011-08-24 The Rockefeller University PLY-GBS-mutante Lysine
US20070071705A1 (en) * 2005-09-29 2007-03-29 De Oliveira Monica A M Topical anti-microbial compositions
SI1937276T1 (sl) 2005-10-12 2013-04-30 Unimed Pharmaceuticals, Llc C/O Abbott Laboratoires 100 Abbott Park Road Izboljšani testosteronski gel in postopek uporabe
JP2007320886A (ja) * 2006-05-31 2007-12-13 Isp Japan Kk 含水ゲル状シート剤及びその製造方法
CA2655809C (en) * 2006-07-21 2013-10-01 Bridge Pharma, Inc. Dermal anesthetic compounds
AU2008351422A1 (en) 2008-02-27 2009-09-03 Allergan, Inc. Dapsone to treat rosascea
US20100029781A1 (en) * 2008-06-04 2010-02-04 Morris Jerome A Methods for preparation of anti-acne formulation and compositions prepared thereby
SG189733A1 (en) 2008-10-10 2013-05-31 Lusomedicamenta S A Antibacterial phage peptides and methods of use thereof
RU2580248C9 (ru) 2009-02-06 2018-01-17 Текнофахе, Инвестигасао Э Десенвольвименто Эм Биотекнолохия, Са Бактериофаг, обладащий активностью против pseudomonas aeruginosa, белки бактериофага и способы их применения
US20110117182A1 (en) * 2009-07-30 2011-05-19 Allergan, Inc. Combination of dapsone with other anti-acne agents
US8999302B1 (en) 2009-10-22 2015-04-07 Aplicare, Inc. Skin dye protectant formulations
PT104837A (pt) 2009-11-24 2011-05-24 Technophage Investiga O E Desenvolvimento Em Biotecnologia S A P?ptidos de fagos enteroc?cicos e m?todos para a sua utiliza??o
KR101656121B1 (ko) 2010-03-17 2016-09-08 노바리크 게엠베하 안압 증가를 치료하기 위한 약학 조성물
PT3443970T (pt) 2010-09-17 2020-10-09 Technophage Investig E Desenvolvimento Em Biotecnologia Sa Fagos antibacterianos, péptidos fágicos e métodos de utilização dos mesmos
EP2444063A1 (de) 2010-10-20 2012-04-25 Novaliq GmbH Flüssige pharmazeutische Zusammensetzungen zur Abgabe von Wirkstoffen
US20130261126A1 (en) 2010-10-21 2013-10-03 Galderma S.A. Brimonidiine gel compositions and methods of use
CN108578685A (zh) 2011-04-21 2018-09-28 洛克菲勒大学 用于革兰氏阳性菌检测和治疗的链球菌属细菌噬菌体溶素
PL2714010T3 (pl) * 2011-05-25 2017-08-31 Novaliq Gmbh Kompozycja farmaceutyczna do miejscowego stosowania oparta na semifluorowanych alkanach
BR112013034059A2 (pt) 2011-06-30 2016-09-06 Allergan Inc composições tópicas retinóides e processos para tratamento de condições de pele
BR112014023321B1 (pt) 2012-03-19 2022-06-14 Technophage, Investigação E Desenvolvimento Em Biotecnologia, Sa Composições compreendendo fagos antibacterianos e seus usos
JP6039152B2 (ja) 2012-09-12 2016-12-07 ノバリック ゲーエムベーハー 半フッ素化アルカン組成物
CN105246457B (zh) * 2012-11-20 2019-06-07 阿勒根公司 局部氨苯砜和氨苯砜/阿达帕林组合物及其使用方法
US9012402B1 (en) 2014-06-11 2015-04-21 James Blanchard Gel for topical delivery of NSAIDs to provide relief of musculoskeletal pain and methods for its preparation
EP3174536A1 (de) 2014-07-31 2017-06-07 Allergan, Inc. Vergleichende wirksamkeit und verträglichkeit von dapson 5% bei erwachsenen im vergleich jugendlichen frauen mitakne vulgaris
DE202016008738U1 (de) 2015-09-30 2019-04-09 Novaliq Gmbh Semifluorierte Verbindungen und ihre Zusammensetzungen
CN108349855B (zh) 2015-09-30 2021-07-20 诺瓦利克有限责任公司 用于眼部给药的半氟化化合物
EP3370711A1 (de) * 2015-11-04 2018-09-12 Allergan, Inc. Verfahren zur behandlung von akne vulgaris mit topischen dapsonzusammensetzungen
ES2763121T3 (es) 2016-06-23 2020-05-27 Novaliq Gmbh Método de administración tópica
CN116172987A (zh) 2016-09-22 2023-05-30 诺瓦利克有限责任公司 用于治疗睑缘炎的药物组合物
US10813976B2 (en) 2016-09-23 2020-10-27 Novaliq Gmbh Ophthalmic compositions comprising ciclosporin
CN110678207A (zh) 2017-04-21 2020-01-10 诺瓦利克有限责任公司 碘组合物
US11278503B2 (en) 2017-05-12 2022-03-22 Novaliq Gmbh Pharmaceutical compositions comprising semifluorinated alkanes for the treatment of contact lense-related conditions
US9895359B1 (en) 2017-06-07 2018-02-20 Arcutis, Inc. Inhibition of crystal growth of roflumilast
US10821075B1 (en) 2017-07-12 2020-11-03 James Blanchard Compositions for topical application of a medicaments onto a mammalian body surface
CN111372566A (zh) 2017-09-27 2020-07-03 诺瓦利克有限责任公司 用于治疗眼部疾病的包含拉坦前列素的眼科用组合物
CN111182893A (zh) 2017-10-04 2020-05-19 诺瓦利克有限责任公司 包含f6h8的眼用组合物
WO2019126670A1 (en) 2017-12-22 2019-06-27 The Rockefeller University Recombinant pseudomonas aeruginosa lysins
SG11202007858VA (en) 2018-03-02 2020-09-29 Novaliq Gmbh Pharmaceutical compositions comprising nebivolol
AU2019345929B2 (en) 2018-09-27 2022-02-03 Dermaliq Therapeutics, Inc. Topical sunscreen formulation
SG11202102820VA (en) 2018-10-12 2021-04-29 Novaliq Gmbh Ophthalmic composition for treatment of dry eye disease
JP2022525221A (ja) 2019-03-14 2022-05-11 クレシタ セラピューティクス インコーポレイテッド 洗い流し組成物および活性剤を送達するためのそれらの使用
US11746352B2 (en) 2019-12-30 2023-09-05 Eligo Bioscience Microbiome modulation of a host by delivery of DNA payloads with minimized spread
IL295172A (en) 2020-01-31 2022-09-01 Arcutis Biotherapeutics Inc Composition of topical roflumilest with improved administration and half-life in plasma
CN115427565A (zh) 2020-04-08 2022-12-02 艾力格生物科技有限公司 通过微生物组的基因治疗来调节微生物群功能以预防、治疗或治愈微生物组相关疾病或障碍
US11617773B2 (en) 2020-04-08 2023-04-04 Eligo Bioscience Elimination of colonic bacterial driving lethal inflammatory cardiomyopathy
US20230220403A1 (en) 2020-06-12 2023-07-13 Eligo Bioscience Specific decolonization of antibiotic resistant bacteria for prophylactic purposes
WO2022003209A1 (en) 2020-07-03 2022-01-06 Eligo Bioscience Method of containment of nucleic acid vectors introduced in a microbiome population
WO2022144382A1 (en) 2020-12-30 2022-07-07 Eligo Bioscience Chimeric receptor binding proteins resistant to proteolytic degradation
WO2022169615A1 (en) 2021-02-05 2022-08-11 Arcutis Biotherapeutics, Inc. Roflumilast formulations with an improved pharmacokinetic profile
WO2023057599A1 (en) 2021-10-07 2023-04-13 Eligo Bioscience Methods involving bacteroides strain replacement
WO2023057598A1 (en) 2021-10-07 2023-04-13 Eligo Bioscience Methods involving bacterial strain replacement

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3867533A (en) * 1968-12-20 1975-02-18 Basf Wyandotte Corp Preparation of aqueous gel compositions containing a water-insoluble organic ingredient
US4731359A (en) * 1980-04-21 1988-03-15 University Of Southern California Prolonged action drug formulation
US4507287A (en) * 1983-06-20 1985-03-26 Dixon Glen J Preparation and method for the treatment of acne
US4853439A (en) * 1987-10-09 1989-08-01 Gaf Corporation Water-soluble complexes of water-insoluble organic compounds
US5180576A (en) * 1991-08-30 1993-01-19 Church & Dwight Co., Inc. Anticalculus dentifrices
GB2260080A (en) * 1991-10-04 1993-04-07 Rhone Poulenc Rorer Ltd Gelled alginate compositions
AU670777B2 (en) * 1992-04-16 1996-08-01 Ortho Pharmaceutical Corporation Aqueous gel vehicles for retinoids
IL104283A (en) * 1992-12-30 1996-12-05 Agis Ind 1983 Ltd Non-emulsion antiviral topical pharmaceutical composition comprising acyclovir an aqueous gel agent and an alkali oleate
GB9408545D0 (en) * 1994-04-29 1994-06-22 Zyma Sa Compositions
KR970705394A (ko) * 1994-09-06 1997-10-09 다께다 가즈히코 연고제 (an ointment preparation)
US5565188A (en) * 1995-02-24 1996-10-15 Nanosystems L.L.C. Polyalkylene block copolymers as surface modifiers for nanoparticles
US5863560A (en) * 1996-09-11 1999-01-26 Virotex Corporation Compositions and methods for topical application of therapeutic agents

Also Published As

Publication number Publication date
US6060085A (en) 2000-05-09
JP2001500863A (ja) 2001-01-23
CA2265461C (en) 2004-11-30
CA2265461A1 (en) 1998-03-19
AU4261097A (en) 1998-04-02
PT957900E (pt) 2004-06-30
DE69727398T2 (de) 2004-11-25
US6620435B1 (en) 2003-09-16
ATE258426T1 (de) 2004-02-15
WO1998010746A1 (en) 1998-03-19
JP2006096774A (ja) 2006-04-13
EP0957900A1 (de) 1999-11-24
AU737365B2 (en) 2001-08-16
DK0957900T3 (da) 2004-06-01
US5863560A (en) 1999-01-26
ES2212128T3 (es) 2004-07-16
JP4276298B2 (ja) 2009-06-10
EP0957900B1 (de) 2004-01-28

Similar Documents

Publication Publication Date Title
DE69727398D1 (de) Zusammensetzungen und verfahren zur topischen anwendungen von wirkstoffen
CA2468539C (en) Delivery of medicaments to the nail
EP0069385B1 (de) Verwendung von Eukalyptol zur Steigerung der Resorption von bioaktiven Substanzen durch die Haut
WO2004078122A3 (en) Invisible patch for active agnet controlled delivery
US20050187212A1 (en) Pharmaceutical composition for topical delivery of meloxicam
DE69833000D1 (de) Biologische kleber und verfahren zur topischen verabreichung von wirkstoffen
AU3211999A (en) An acidified composition for topical treatment of nail and skin conditions
JP2003514875A (ja) 創傷治癒を改善し、薬を投与するためのプロペラント不要のスプレー式皮膚パッチ組成物
AU1313299A (en) Penetration enhancing and irritation reducing systems
WO1987002580A1 (en) Film-forming, pharmaceutical vehicles for application of medicaments to nails, pharmaceutical compositions based on those vehicles, and methods of using same
ATE288743T1 (de) Pharmazeutische trägervorrichtung welche zur verabreichung von wirkstoffen an schleimhautoberflächen geeignet ist
WO2007120868A2 (en) Bioavailability enhancement of lipophilic drug by use solvent system
CA2494473A1 (en) Stabilized protein compositions for topical administration and methods of making same
WO1999026589A3 (en) Composition for the treatment of burns, sunburns, abrasions, ulcers and cutaneous irritation
WO1994017792A3 (en) Compositions and methods for transdermal drug delivery
JPH02207024A (ja) 経皮吸収製剤
AU5190790A (en) Percutaneous drug delivery system
IE51016B1 (en) Composition of matter for topical application comprising a bio-affecting agent and n,n-diethyl-m-toluamide
JPH0778026B2 (ja) 皮膚用外用基剤
Shivakumar et al. Topical nail formulations
EP0748216A1 (de) Systemischer wirkstoffverabreichungssystem durch anwendung auf den nageln
JP2002060349A (ja) 皮膚外用剤
JP3548195B2 (ja) 経皮吸収型製剤
WO2007056068A3 (en) Macrocyclic formulations for transmembrane drug delivery
Hollingsbee et al. The effect of a hydrocolloid dermatological patch (Actiderm) in potentiating the skin blanching activity of triamcinolone acetonide

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: QLT USA, INC. (N.D.GES.D. STAATES DELAWARE), , US

8328 Change in the person/name/address of the agent

Representative=s name: PATENTANWAELTE LEIFERT & STEFFAN, 40213 DUESSELDOR